An-rong Mao - Publications

Adjuvant tislelizumab, lenvatinib, and capecitabine for resected biliary tract cancer: a prospective phase II trial.

Journal: BMC medicine

Published: June 18, 2025

Organoid modeling identifies USP3-AS1 as a novel promoter in colorectal cancer liver metastasis through increasing glucose-driven histone lactylation.

Journal: Acta pharmacologica Sinica

Published: October 01, 2024

Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy.

Journal: Frontiers in oncology

Published: November 21, 2022

A Practical Risk Classification of Early Recurrence in Hepatocellular Carcinoma Patients with Microvascular invasion after Hepatectomy: A Decision Tree Analysis.

Journal: Annals of surgical oncology

Published: June 13, 2022

Value and prognostic factors of repeat hepatectomy for recurrent colorectal liver metastasis.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: June 03, 2022

Hepatic resection prolongs overall survival in the selected patients with nasopharyngeal carcinoma liver metastases.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: April 19, 2022

Enhanced recovery after surgery program in the patients undergoing hepatectomy for benign liver lesions.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: September 15, 2019

Simvastatin decreases hyperbaric oxygen-induced acute lung injury by upregulating eNOS.

Journal: American journal of physiology. Lung cellular and molecular physiology

Published: October 28, 2017